PharVision Advisers »

Goodrx Hldgs shares owned by PharVision Advisers

Quarter-by-quarter ownership of Goodrx Hldgs (GDRX) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Goodrx Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Goodrx Hldgs held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Goodrx Hldgs by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $172k 41k 4.23

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Goodrx Hldgs

Francisco Partners Management
Vanguard Group
Ameriprise Financial
Silver Lake Group
Renaissance Technologies
Petrus Trust Company
LSV Asset Management
Dimensional Fund Advisors
BlackRock
Prescott Group Capital Management
Goldman Sachs Group
Technology Crossover Management X
Citadel Advisors
Lakewood Capital Management
Connor, Clark & Lunn Investment Management

View all funds holding Goodrx Hldgs